Can a doctor prescribe Selank in the United States?

No. There is no FDA-approved Selank product to prescribe, and no listed bulk substance for a compounding pharmacy to prepare it from. A prescriber willing to write for it would be writing for something that does not exist in the pharmacy system.

Is Selank a controlled substance?

We have found nothing placing Selank on a federal controlled substances schedule, and we are not going to assert a legal status we cannot source. What is documented is that it is unapproved, absent from the 503A bulks list, and sold in the research channel.

Does a withdrawn nomination mean the FDA cleared it?

No, and it does not mean the FDA condemned it either. The nominator stopped pursuing the listing, so the evaluation never concluded. The agency's attached statement says it lacks important information about safety issues raised by selank acetate administered to humans, which is a statement about missing evidence.

What does the Russian registration mean for a US buyer?

Legally, nothing. Russia registered Selank as an anxiolytic under its own system. That is not an FDA approval, does not create a US prescription route, and is not evidence a reader here can independently evaluate without reading the underlying Russian literature.

If it is sold without a prescription, is it safe to use?

That does not follow, and this page will not pretend otherwise. Sold without a prescription means sold outside the system that would normally assess it. The FDA's stated concern is immunogenicity from aggregation and peptide-related impurities, and whether endotoxin and sterility testing covers your vial depends on which batch you are sent.

Selank Without Prescription: No List, No Approval, No Script

Summary: The reason you cannot get a prescription for Selank is not that doctors are cautious, it is that there is no approved product to prescribe and no listed bulk substance to compound from.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Buying Selank without prescription is not a workaround, a loophole or a grey-area shortcut. It is the only way the substance is sold in the United States, because there is no approved product a doctor could write for and no listed bulk substance a pharmacy could compound from. This page sets out exactly why, with dates, because most pages covering it are working from an outdated version of the facts.

Where readers actually buy it

Ascension Peptides — Selank

Research-grade Selank, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off

Selank · 10 mg$47.50$23.75$2.38/mgGet the 10 mg →

The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

Batch certificates from two independent labs
Free shipping over $250
Ships same day if ordered before 2pm CST

Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 21, 2026.

This is the most careful page in this section of the site. Everything below was checked against the primary source rather than repeated from another article.

What Selank is

A synthetic heptapeptide: seven amino acids in the order Thr-Lys-Pro-Arg-Pro-Gly-Pro, formula C33H57N11O9, molecular weight 751.9, catalogued as PubChem CID 11765600 ^[4]. The first four residues are tuftsin, a short immune-signalling peptide the body produces on its own, and the trailing Pro-Gly-Pro is an engineered addition that slows enzymatic breakdown. FDA paperwork names it selank acetate, or TP-7.

It was developed in Russia and is registered there as an anxiolytic. That is a true statement about Russian regulation. It is not an FDA approval, not a Western evidence base, and not something this site treats as demonstrated. For readers arriving from GLP-1 content, the contrast is the point: Selank is not a GLP-1, not an incretin, and not supported by anything resembling the trial programme behind the drugs this site normally covers.

Selank without prescription: three things the phrase can mean

People type this phrase meaning three quite different situations, and only one of them applies here.

What the phrase can mean	Does it apply to Selank	Why
An over-the-counter medicine you buy without seeing a prescriber	No	There is no approved Selank drug product in any format, so there is nothing to sell over a counter
A compounded preparation you would normally need a prescription for, obtained another way	No	A compounding pharmacy has no lawful bulk substance to compound from, so the prescription version does not exist to be obtained
Material sold outside the medicine system entirely, for laboratory use	Yes	This is the whole US market: research vials, labelled not for human consumption

The third row is the honest answer. It is also the one that comes with the fewest protections, which is worth being clear-eyed about rather than reassuring about.

The regulatory position, in order and with dates

Four statements, each checkable in a couple of minutes.

One: there is no FDA approval for Selank for any indication. No approved product, no label, no prescribing information, and therefore no prescriber who can lawfully write for it as a finished drug.

Two: Selank acetate was nominated for the 503A bulks list, and the nomination was withdrawn. The 503A bulks list governs which bulk drug substances a compounding pharmacy may use when no approved product covers the need. Substances get sorted into categories while the agency evaluates them. Selank acetate went through nomination and the nominator pulled it.

Three: Selank appears on no current category of that list. The FDA's 503A bulks list page, content current as of 14 May 2026, does not name Selank anywhere in Category 1, Category 2 or Category 3 ^[2].

Four: it appears on the FDA's safety page under the heading for withdrawn nominations. On the compounding safety-risks page, content current as of 22 April 2026, "Selank acetate (TP-7)" is listed under "Bulk drug substances nominated but withdrawn", with a risk statement attached ^[1].

Here is that risk statement, quoted exactly, because paraphrase has been doing damage to it:

Compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA lacks important information regarding any safety issues raised by selank acetate administered to humans.

Two claims sit in those two sentences. The first is a mechanism: aggregation and peptide-related impurities can provoke an immune response, and the risk is route-dependent. The second is an absence: the agency does not have the human safety information it would need to say more. Neither sentence says Selank is dangerous and neither says it is safe. They say it has not been characterised, and they name the specific way it could go wrong.

The "Category 2" error, and why it matters

A large share of pages covering this topic state that Selank is FDA Category 2, or that it has been banned from compounding. Both are wrong, and it is easy to check.

Current Category 2 under the 503A interim policy holds six substances: cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10, and quinacrine hydrochloride for intrauterine administration. Selank is not among them. It is on the withdrawn-nominations list instead, which is a different list on the same page with a different legal meaning.

The distinction is not pedantry. A Category 2 placement is an active FDA determination that a substance presents significant safety risks. A withdrawn nomination means the party who nominated it stopped pursuing it, so the evaluation never concluded. Selank ended up outside the system rather than judged and rejected by it. If you are trying to work out how much weight to put on the regulatory record, that difference is most of the answer.

It also has company. The same withdrawn-nominations list carries BPC-157, MOTs-C, Semax, TB-500 and a dozen other compounds sold in the same research channel, each with a nearly identical immunogenicity paragraph. Our pages on BPC-157 without a prescription and MOTS-c without a prescription work through the same position for those two, and reading any of the three tells you how the whole category is regulated, which is to say barely.

What a research-use sale actually is

The vials sold in this market are sold for laboratory research and not for human consumption, and that phrase is doing legal work rather than decorating the label. It means the seller is not offering a drug, is making no therapeutic claim, and takes on none of the obligations that attach to one.

What it means for you is a short list of things that are not there. There is no prescriber assessing whether the substance is appropriate for you. There is no pharmacist checking interactions. There is no manufacturer holding an approved application and therefore no adverse-event reporting obligation attached to a marketed product. There is no recall mechanism aimed at consumers. There is no insurance claim, because there is nothing approved to reimburse. The FDA's own compounding explainer is a useful thing to read alongside this, if only to see how much apparatus exists around a lawful compounded preparation that simply is not present here ^[3].

None of that makes the purchase unlawful. It makes it unsupervised, which is a different thing and the accurate thing to say. Our page on the routes to Selank ranked by friction sets out what each one actually asks of you once the prescription option is off the table.

Where the withdrawal leaves a buyer

With one job, and it is a document-reading job. If the regulator's stated concern is immunogenicity arising from aggregation and peptide-related impurities, then purity, identity and contamination testing are not optional extras on a certificate. They are the entire response available to a buyer.

The certificate published for Selank lot 29-01260229, analysed by MZ Biolabs in Tucson on 7 February 2026, reports purity of 99.32% by HPLC-UV, identity confirmed by mass spectrometry against an expected monoisotopic mass of 751.43 Da with 751.47 Da measured, and a measured quantity of 12.29 mg in a vial labelled 10 mg ^[5]. Those are good numbers, and the quantification figure in particular is something most vendors do not publish. The document contains no bacterial endotoxin test, no LAL result, no pyrogen test and no sterility screen. We searched it rather than assuming. The same vendor's June 2026 Selank batch, 29-05260628, does carry an endotoxin safety screen against a 0.5 EU/mL limit and a rapid sterility screen returning no growth, from a different laboratory four months later. Which testing you get is a batch question rather than a product question, because the scope widened across the catalogue in June, so read every certificate on the product page rather than only the one that is a clickable link.

That is the practical shape of buying without a prescription. Nobody upstream is going to do the checking, the checking that is available to you is narrow, and on the February lot part of it is missing. Our page on retatrutide without a prescription makes the same argument about a compound that at least has published human trial data behind it. Selank does not have that, which raises the weight the certificate has to carry.

Common questions about Selank without a prescription

Can a doctor prescribe Selank in the United States?: No. There is no FDA-approved Selank product to prescribe, and no listed bulk substance for a compounding pharmacy to prepare it from. A prescriber willing to write for it would be writing for something that does not exist in the pharmacy system.
Is Selank a controlled substance?: We have found nothing placing Selank on a federal controlled substances schedule, and we are not going to assert a legal status we cannot source. What is documented is that it is unapproved, absent from the 503A bulks list, and sold in the research channel.
Is Selank FDA Category 2?: No. Category 2 under the 503A interim policy currently holds cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10 and quinacrine hydrochloride for intrauterine administration. Selank appears instead on the separate list of substances nominated but withdrawn.
Does a withdrawn nomination mean the FDA cleared it?: No, and it does not mean the FDA condemned it either. The nominator stopped pursuing the listing, so the evaluation never concluded. The agency's attached statement says it lacks important information about safety issues raised by selank acetate administered to humans, which is a statement about missing evidence.
What does the Russian registration mean for a US buyer?: Legally, nothing. Russia registered Selank as an anxiolytic under its own system. That is not an FDA approval, does not create a US prescription route, and is not evidence a reader here can independently evaluate without reading the underlying Russian literature.
If it is sold without a prescription, is it safe to use?: That does not follow, and this page will not pretend otherwise. Sold without a prescription means sold outside the system that would normally assess it. The FDA's stated concern is immunogenicity from aggregation and peptide-related impurities, and whether endotoxin and sterility testing covers your vial depends on which batch you are sent.

The short version

There is no prescription route for Selank in the United States and there is nothing to be worked around. No approved product exists, the 503A nomination for selank acetate was withdrawn, and as of the FDA's 14 May 2026 update it is absent from Categories 1, 2 and 3 of that list. It appears on the agency's safety page only under withdrawn nominations, with a risk statement naming immunogenicity from aggregation and peptide-related impurities and an admission that the agency lacks important information about human safety. Everything sold in the US is research material. The only protection available to a buyer is a batch certificate, and its scope depends on the batch: the February one is strong on purity, identity and mass and silent on endotoxin and sterility, while the June one carries both.